shadforth pharmaceutical company limited

4

shadforth pharmaceutical company limited Company Information

Share SHADFORTH PHARMACEUTICAL COMPANY LIMITED
Live 
MatureMidHealthy

Company Number

00143500

Registered Address

unit 13 4 cromar way, chelmsford, essex, CM1 2GL

Industry

Dispensing chemist in specialised stores

 

Telephone

01245359722

Next Accounts Due

October 2024

Group Structure

View All

Directors

Richard Shadforth33 Years

Thomas Shadforth12 Years

Shareholders

shadforth holdings limited 100%

shadforth pharmaceutical company limited Estimated Valuation

£3.3m

Pomanda estimates the enterprise value of SHADFORTH PHARMACEUTICAL COMPANY LIMITED at £3.3m based on a Turnover of £9.2m and 0.36x industry multiple (adjusted for size and gross margin).

shadforth pharmaceutical company limited Estimated Valuation

£0

Pomanda estimates the enterprise value of SHADFORTH PHARMACEUTICAL COMPANY LIMITED at £0 based on an EBITDA of £-2.5m and a 5.31x industry multiple (adjusted for size and gross margin).

shadforth pharmaceutical company limited Estimated Valuation

£3.5m

Pomanda estimates the enterprise value of SHADFORTH PHARMACEUTICAL COMPANY LIMITED at £3.5m based on Net Assets of £1.4m and 2.48x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Shadforth Pharmaceutical Company Limited Overview

Shadforth Pharmaceutical Company Limited is a live company located in essex, CM1 2GL with a Companies House number of 00143500. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in April 1916, it's largest shareholder is shadforth holdings limited with a 100% stake. Shadforth Pharmaceutical Company Limited is a mature, mid sized company, Pomanda has estimated its turnover at £9.2m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Shadforth Pharmaceutical Company Limited Health Check

Pomanda's financial health check has awarded Shadforth Pharmaceutical Company Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4out of 5
positive_score

4 Strong

positive_score

4 Regular

positive_score

4 Weak

size

Size

annual sales of £9.2m, make it in line with the average company (£11.1m)

£9.2m - Shadforth Pharmaceutical Company Limited

£11.1m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 7%, show it is growing at a faster rate (5.2%)

7% - Shadforth Pharmaceutical Company Limited

5.2% - Industry AVG

production

Production

with a gross margin of 32.3%, this company has a comparable cost of product (32.3%)

32.3% - Shadforth Pharmaceutical Company Limited

32.3% - Industry AVG

profitability

Profitability

an operating margin of -27.8% make it less profitable than the average company (5.1%)

-27.8% - Shadforth Pharmaceutical Company Limited

5.1% - Industry AVG

employees

Employees

with 122 employees, this is above the industry average (83)

122 - Shadforth Pharmaceutical Company Limited

83 - Industry AVG

paystructure

Pay Structure

on an average salary of £21.8k, the company has an equivalent pay structure (£21.8k)

£21.8k - Shadforth Pharmaceutical Company Limited

£21.8k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £75.4k, this is less efficient (£128.8k)

£75.4k - Shadforth Pharmaceutical Company Limited

£128.8k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 31 days, this is near the average (29 days)

31 days - Shadforth Pharmaceutical Company Limited

29 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 42 days, this is quicker than average (70 days)

42 days - Shadforth Pharmaceutical Company Limited

70 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 39 days, this is more than average (31 days)

39 days - Shadforth Pharmaceutical Company Limited

31 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 22 weeks, this is more cash available to meet short term requirements (17 weeks)

22 weeks - Shadforth Pharmaceutical Company Limited

17 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 36.3%, this is a lower level of debt than the average (63.7%)

36.3% - Shadforth Pharmaceutical Company Limited

63.7% - Industry AVG

SHADFORTH PHARMACEUTICAL COMPANY LIMITED financials

EXPORTms excel logo

Shadforth Pharmaceutical Company Limited's latest turnover from January 2023 is estimated at £9.2 million and the company has net assets of £1.4 million. According to their latest financial statements, Shadforth Pharmaceutical Company Limited has 122 employees and maintains cash reserves of £332.8 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Jan 2023Jan 2022Jan 2021Jan 2020Jan 2019Jan 2018Jan 2017Jan 2016Jan 2015Jan 2014Jan 2013Jan 2012Jan 2011Jan 2010
Turnover9,199,3068,276,12010,441,6427,458,3698,996,4478,765,1588,710,0458,634,2058,428,0318,467,3798,738,5908,960,6439,330,5609,068,554
Other Income Or Grants00000000000000
Cost Of Sales6,231,7315,606,6987,292,3715,294,7866,313,5796,350,3816,198,6626,007,5426,043,4206,000,8386,156,8216,603,4396,548,5736,268,749
Gross Profit2,967,5752,669,4223,149,2712,163,5832,682,8682,414,7772,511,3832,626,6632,384,6112,466,5412,581,7692,357,2042,781,9872,799,805
Admin Expenses5,524,4972,325,9712,825,4592,241,2942,839,0532,309,0202,338,7842,371,8062,317,1582,307,3782,260,1122,152,2192,109,5262,320,947
Operating Profit-2,556,922343,451323,812-77,711-156,185105,757172,599254,85767,453159,163321,657204,985672,461478,858
Interest Payable0000000000000122,000
Interest Receivable30,2933,2241,2239,76710,7256904,3115,1525,4285,1048,78034,74134,66235,972
Pre-Tax Profit-2,526,629346,675325,035-67,944-145,460106,447176,910260,00972,881164,267330,437226,640707,123392,830
Tax0-65,868-61,75700-19,865-35,906-50,390-6,740-39,710-63,302-51,986-186,964-126,262
Profit After Tax-2,526,629280,807263,278-67,944-145,46086,582141,004209,61966,141124,557267,135174,654520,159266,568
Dividends Paid00000100,800100,800100,800162,000170,300157,200188,954220,800146,160
Retained Profit-2,526,629280,807263,278-67,944-145,460-14,21840,204108,819-95,859-45,743109,935-14,300299,359120,408
Employee Costs2,657,9682,474,1872,315,4492,258,5212,083,1432,071,5772,055,2672,079,1551,969,4301,969,6201,933,0131,828,7941,684,0761,663,362
Number Of Employees12212212012111311111111311311311110410096
EBITDA*-2,523,183378,888363,072-30,171-116,166147,235220,545307,314114,796211,013350,956231,255687,190489,199

* Earnings Before Interest, Tax, Depreciation and Amortisation

Jan 2023Jan 2022Jan 2021Jan 2020Jan 2019Jan 2018Jan 2017Jan 2016Jan 2015Jan 2014Jan 2013Jan 2012Jan 2011Jan 2010
Tangible Assets162,4652,272,9521,743,5881,718,7151,320,0451,312,3691,307,4261,330,0511,331,9851,316,5651,123,410747,499657,374645,070
Intangible Assets00000000000000
Investments & Other00000000000000
Debtors (Due After 1 year)00000000000000
Total Fixed Assets162,4652,272,9521,743,5881,718,7151,320,0451,312,3691,307,4261,330,0511,331,9851,316,5651,123,410747,499657,374645,070
Stock & work in progress680,027589,059537,100567,909565,233547,228493,236531,608549,116534,406591,173596,089602,089577,492
Trade Debtors785,241622,1151,447,518699,2631,198,0251,300,9601,252,6111,314,996627,308636,0951,370,7311,468,4271,497,992806,260
Group Debtors00000000000000
Misc Debtors284,262209,593189,608211,140207,068194,276194,327185,580205,920471,236242,280206,462198,934177,109
Cash332,7521,398,2731,181,2191,264,0771,340,4801,519,4261,800,9251,650,3272,320,1282,435,8352,060,6832,173,1751,440,7591,355,724
misc current assets000000000000997,813997,813
total current assets2,082,2822,819,0403,355,4452,742,3893,310,8063,561,8903,741,0993,682,5113,702,4724,077,5724,264,8674,444,1534,737,5873,914,398
total assets2,244,7475,091,9925,099,0334,461,1044,630,8514,874,2595,048,5255,012,5625,034,4575,394,1375,388,2775,191,6525,394,9614,559,468
Bank overdraft00000000000000
Bank loan00000000000000
Trade Creditors 725,249880,357854,348847,136952,246899,473897,036898,572995,8281,181,4111,084,9321,041,2021,122,268629,425
Group/Directors Accounts3,1670000000000000
other short term finances00000000000000
hp & lease commitments00000000000000
other current liabilities53,288227,963536,820163,381144,355307,295468,780466,985500,443575,281647,357602,147727,685687,366
total current liabilities781,7041,108,3201,391,1681,010,5171,096,6011,206,7681,365,8161,365,5571,496,2711,756,6921,732,2891,643,3491,849,9531,316,791
loans0000000000000500
hp & lease commitments00000000000000
Accruals and Deferred Income00000000000000
other liabilities000017,719000000000
provisions34,00028,00033,00039,00037,00042,50043,50047,50047,50050,90023,70025,9508,3555,383
total long term liabilities34,00028,00033,00039,00054,71942,50043,50047,50047,50050,90023,70025,9508,3555,883
total liabilities815,7041,136,3201,424,1681,049,5171,151,3201,249,2681,409,3161,413,0571,543,7711,807,5921,755,9891,669,2991,858,3081,322,674
net assets1,429,0433,955,6723,674,8653,411,5873,479,5313,624,9913,639,2093,599,5053,490,6863,586,5453,632,2883,522,3533,536,6533,236,794
total shareholders funds1,429,0433,955,6723,674,8653,411,5873,479,5313,624,9913,639,2093,599,5053,490,6863,586,5453,632,2883,522,3533,536,6533,236,794
Jan 2023Jan 2022Jan 2021Jan 2020Jan 2019Jan 2018Jan 2017Jan 2016Jan 2015Jan 2014Jan 2013Jan 2012Jan 2011Jan 2010
Operating Activities
Operating Profit-2,556,922343,451323,812-77,711-156,185105,757172,599254,85767,453159,163321,657204,985672,461478,858
Depreciation33,73935,43739,26047,54040,01941,47847,94652,45747,34351,85029,29926,27014,72910,341
Amortisation00000000000000
Tax0-65,868-61,75700-19,865-35,906-50,390-6,740-39,710-63,302-51,986-186,964-126,262
Stock90,96851,959-30,8092,67618,00553,992-38,372-17,50814,710-56,767-4,916-6,00024,597577,492
Debtors237,795-805,418726,723-494,690-90,14348,298-53,638667,348-274,103-505,680-61,878-22,037713,557983,369
Creditors-155,10826,0097,212-105,11052,7732,437-1,536-97,256-185,58396,47943,730-81,066492,843629,425
Accruals and Deferred Income-174,675-308,857373,43919,026-162,940-161,4851,795-33,458-74,838-72,07645,210-125,53840,319687,366
Deferred Taxes & Provisions6,000-5,000-6,0002,000-5,500-1,000-4,0000-3,40027,200-2,25017,5952,9725,383
Cash flow from operations-3,175,729778,631-19,948377,759-159,695-134,968272,908-523,630103,628785,353441,13818,297298,206124,250
Investing Activities
capital expenditure2,076,748-564,801-64,133-446,210-47,695-48,043-25,321-49,687-62,964-245,005-405,210868,332-25,405-16,205
Change in Investments00000000000000
cash flow from investments2,076,748-564,801-64,133-446,210-47,695-48,043-25,321-49,687-62,964-245,005-405,210868,332-25,405-16,205
Financing Activities
Bank loans00000000000000
Group/Directors Accounts3,1670000000000000
Other Short Term Loans 00000000000000
Long term loans000000000000-500500
Hire Purchase and Lease Commitments00000000000000
other long term liabilities000-17,71917,719000000000
share issue000000-500000005003,116,386
interest30,2933,2241,2239,76710,7256904,3115,1525,4285,1048,78034,74134,662-86,028
cash flow from financing33,4603,2241,223-7,95228,4446903,8115,1525,4285,1048,78034,74134,6623,030,858
cash and cash equivalents
cash-1,065,521217,054-82,858-76,403-178,946-281,499150,598-669,801-115,707375,152-112,492732,41685,0351,355,724
overdraft00000000000000
change in cash-1,065,521217,054-82,858-76,403-178,946-281,499150,598-669,801-115,707375,152-112,492732,41685,0351,355,724

shadforth pharmaceutical company limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for shadforth pharmaceutical company limited. Get real-time insights into shadforth pharmaceutical company limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Shadforth Pharmaceutical Company Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for shadforth pharmaceutical company limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in CM1 area or any other competitors across 12 key performance metrics.

shadforth pharmaceutical company limited Ownership

SHADFORTH PHARMACEUTICAL COMPANY LIMITED group structure

Shadforth Pharmaceutical Company Limited has no subsidiary companies.

Ultimate parent company

1 parent

SHADFORTH PHARMACEUTICAL COMPANY LIMITED

00143500

SHADFORTH PHARMACEUTICAL COMPANY LIMITED Shareholders

shadforth holdings limited 100%

shadforth pharmaceutical company limited directors

Shadforth Pharmaceutical Company Limited currently has 2 directors. The longest serving directors include Mr Richard Shadforth (Oct 1991) and Mr Thomas Shadforth (Jan 2012).

officercountryagestartendrole
Mr Richard ShadforthUnited Kingdom83 years Oct 1991- Director
Mr Thomas ShadforthUnited Kingdom52 years Jan 2012- Director

P&L

January 2023

turnover

9.2m

+11%

operating profit

-2.6m

0%

gross margin

32.3%

+0.01%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

January 2023

net assets

1.4m

-0.64%

total assets

2.2m

-0.56%

cash

332.8k

-0.76%

net assets

Total assets minus all liabilities

shadforth pharmaceutical company limited company details

company number

00143500

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

April 1916

age

108

incorporated

UK

ultimate parent company

accounts

Total Exemption Full

last accounts submitted

January 2023

previous names

N/A

accountant

-

auditor

-

address

unit 13 4 cromar way, chelmsford, essex, CM1 2GL

Bank

BARCLAYS BANK PLC

Legal Advisor

-

shadforth pharmaceutical company limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 4 charges/mortgages relating to shadforth pharmaceutical company limited. Currently there are 1 open charges and 3 have been satisfied in the past.

charges

shadforth pharmaceutical company limited Companies House Filings - See Documents

datedescriptionview/download